UF College of Pharmacy researchers aim to improve health equity in diabetes care
A four-year study aims to identify the patient groups who would benefit most from newer glucose-lowering drugs.
A four-year study aims to identify the patient groups who would benefit most from newer glucose-lowering drugs.
The project aims to identify barriers and facilitators to the enrollment and completion of the National Diabetes Prevention Program and evaluate its long-term effectiveness and cost-effectiveness.
Congratulations to the following UF College of Pharmacy faculty who were promoted and/or earned tenure on July 1, 2022.
The UF College of Pharmacy secured a record $32.3 million in research funding last year.
The honor recognizes individuals whose original research reflects new and relevant insights in geriatrics and who are committed to a career in aging research.
A modeling study published in JAMA Network Open estimates the years that might be added to the life span of someone with Type 2 diabetes with improved control of the disease.
Almut Winterstein, Ph.D., joined the From Florida podcast with Nicci Brown to discuss medical marijuana research.
Goodin has been appointed as a Center for Public Health Law Research Fellow for a two-year term.
The award recognizes Park for her excellence, innovation and effectiveness in mentoring doctoral students throughout their dissertation project.
The awards are given annually to the top scoring abstracts submitted by clinical pharmacologists and translational scientists in training, and UF College of Pharmacy trainees won 7 of the 21 awards presented in 2022.